Culturally-adapted Mobile Health Intervention for Hypertension Care
Not Applicable
- Conditions
- Hypertension
- Registration Number
- NCT06985199
- Lead Sponsor
- Tufts University
- Brief Summary
A single-arm study to assess the ability of the AHOMKA platform for hypertension management to affect blood pressure change among urban and rural patients in Ghana.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ENROLLING_BY_INVITATION
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
- diagnosis of hypertension
Exclusion Criteria
- Comorbidities
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Change in Blood Pressure levels from Baseline Baseline, 6 months Changes in blood pressure levels, measured in mmHg, will be assessed at the baseline and 6-month endline visit.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does the Medtronic Empower Health Platform target in hypertension management?
How does the AHOMKA mHealth intervention compare to standard-of-care antihypertensives in Ghanaian populations?
Which biomarkers correlate with improved adherence to mobile health interventions in rural hypertension patients?
What adverse events are associated with culturally tailored digital hypertension platforms in low-resource settings?
Are there combination therapies integrating mHealth tools like AHOMKA with ACE inhibitors for resistant hypertension in Africa?
Trial Locations
- Locations (2)
National Cardiothoracic Center
🇬🇭Accra, Ghana
Cardiothoracic Center - Outpatient Department
🇬🇭Ho, Ghana
National Cardiothoracic Center🇬🇭Accra, Ghana